Boragen Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 14
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $7M
Latest Deal Amount
  • Investors
  • 11

Boragen General Information


Developer of a novel synthetic chemistry platform designed to produce next-generation fungicides. The company's platform supports sustainable farming methods by creating a compound that decreases the probability of fungicide resistance and reduces the amount of chemical applied while maintaining performance and efficacy, enabling users to address unmet needs and challenges across multiple sectors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Agriculture
Other Commercial Products
Primary Office
  • Research Triangle Park, Post Office Box 110066
  • 5 Laboratory Drive, Suite 2150
  • Durham, NC 27709
  • United States
+1 (919) 000-0000

Boragen Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Boragen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 15-May-2020 $7M 000.00 Completed Generating Revenue
3. Early Stage VC 06-Jul-2018 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 22-Mar-2017 $10.5M $10.5M 000.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
To view Boragen’s complete valuation and funding history, request access »

Boragen Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Boragen’s complete cap table history, request access »

Boragen Executive Team (8)

Name Title Board Seat Contact Info
Roger Kemble Ph.D Chief Executive Officer, Chairman & Scientific Advisory Board Member
Richard Gianni Chief Financial Officer & Controller
C. Tony Liu Ph.D Co-Founder & Chief Scientific Officer
Gerald Fink Ph.D Co-Founder
Lucy Shapiro Ph.D Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Boragen Board Members (7)

Name Representing Role Since
Joel Marcus JD Alexandria Venture Investments Board Member 000 0000
Kristina Burow ARCH Venture Partners Board Member 000 0000
Paul Schimmel Ph.D Self Co-Founder & Board Member 000 0000
Raj Kaul Self Board Member 000 0000
Rob Readnour Ph.D Mountain Group Partners Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Boragen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boragen Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Bayer Corporation Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Elanco Animal Health Corporation Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »